Patents by Inventor Magdalena JASTRZEBSKA-WIESEK

Magdalena JASTRZEBSKA-WIESEK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of selective serotonin 5-HTreceptor agonists for treating side-effects of VMAT inhibitors
    Patent number: 11191758
    Abstract: The present invention relates to the reduction of the side-effects induced by tetrabenazine or other inhibitors of vesicular monoamine transporter (VMAT), in the treatment of central nervous system disorders such as Huntington's disease, L-DOPA-induced dyskinesias in Parkinson's disease, Tourette's syndrome or tardive dyskinesia. The invention comprises administering to a patient in need thereof an effective amount of activates selective serotonin 5-HT1A receptors agonist, whereby the side-effects of depression or Parkinsonism induced by tetrabenazine or other VMAT inhibitors are minimized.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: December 7, 2021
    Assignees: Neurolixis, Uniwersytet Jagiellonski Collegium Medicum
    Inventors: Anna Wesolowska, Magdalena Jastrzebska-Wiesek, Adrian Newman-Tancredi, Mark Andrew Varney
  • Use Of Selective Serotonin 5-HT1A Receptor Agonists For Treating Side-Effects Of VMAT Inhibitors
    Publication number: 20200155535
    Abstract: The present invention relates to the reduction of the side-effects induced by tetrabenazine or other inhibitors of vesicular monoamine transporter (VMAT), in the treatment of central nervous system disorders such as Huntington's disease, L-DOPA-induced dyskinesias in Parkinson's disease, Tourette's syndrome or tardive dyskinesia.
    Type: Application
    Filed: July 20, 2018
    Publication date: May 21, 2020
    Inventors: Anna WESOLOWSKA, Magdalena JASTRZEBSKA-WIESEK, Adrian NEWMAN-TANCREDI, Mark Andrew VARNEY